The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Delivering Nanoparticles to Lungs while Avoiding Liver and Spleen through Adsorption on Red Blood Cells
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Prior literature has shown that RBC‐association enhances the circulation of polymeric nanoparticles.”
From Hyaluronic a cid–doxorubicin nanoparticles for targeted treatment of colorectal cancer (2021) · cites this paper as [83]
In the citing paper
“Unlike most nanoparticles that are able to adsorb onto RBC, 83 , 84 HA‐Dox does not accumulate in the lungs, rather it accumulates in the intestines.”
From Hyaluronic a cid–doxorubicin nanoparticles for targeted treatment of colorectal cancer (2021) · cites this paper as [83]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Targeted delivery of nanoparticles for the treatment of lung diseases
Azarmi, S., Roa, W. H., & Löbenberg, R. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.11.006 · Cited by 440
Flagged first, then by citations
Research works printed but not linked: 49
- Faraji A. H., 2009, Bioorg. Med. Chem., 17, 2950, 10.1016/j.bmc.2009.02.043 · DOI
- Wang A. Z., 2012, Annu. Rev. Med., 63, 185, 10.1146/annurev-med-040210-162544 · DOI
- Dhar S., 2008, Proc. Natl. Acad. Sci. U.S.A., 105, 17356, 10.1073/pnas.0809154105 · DOI
- Peer D., 2007, Nat. Nanotechnol., 2, 751, 10.1038/nnano.2007.387 · DOI · Paper page
- Brannon-Peppas L., 2004, Adv. Drug Delivery Rev., 56, 1649, 10.1016/j.addr.2004.02.014 · DOI
- Hrkach J., 2012, Sci. Transl. Med., 4, 128, 10.1126/scitranslmed.3003651 · DOI
- Kattan J., 1992, Invest. New Drugs, 10, 191, 10.1007/BF00877245 · DOI
- Green M. R., 2006, Ann. Oncol., 17, 1263, 10.1093/annonc/mdl104 · DOI
- Hofheinz R. D., 2005, Anticancer Drugs, 16, 691, 10.1097/01.cad.0000167902.53039.5a · DOI
- Allen T. M., 2004, Science, 303, 1818, 10.1126/science.1095833 · DOI · Paper page
- Ruoslahti E., 2012, Adv. Mater., 24, 3747, 10.1002/adma.201200454 · DOI
- Yoo J. W., 2010, Curr. Pharm. Des., 16, 2298, 10.2174/138161210791920496 · DOI
- Riehemann K., 2009, Angew. Chem., Int. Ed. Engl., 48, 872, 10.1002/anie.200802585 · DOI
- Sanhai W. R., 2008, Nat. Nanotechnol., 3, 242, 10.1038/nnano.2008.114 · DOI
- Perry J. L., 2012, Nano Lett., 12, 5304, 10.1021/nl302638g · DOI
- Bazile D., 1995, J. Pharm. Sci., 84, 493, 10.1002/jps.2600840420 · DOI
- Ishida T., 2003, J. Controlled Release, 88, 35, 10.1016/S0168-3659(02)00462-5 · DOI
- Ishida T., 2003, Int. J. Pharm., 255, 167, 10.1016/S0378-5173(03)00085-1 · DOI
- Ishida T., 2006, J. Controlled Release, 112, 15, 10.1016/j.jconrel.2006.01.005 · DOI
- Rodriguez P. L., 2013, Science, 339, 971, 10.1126/science.1229568 · DOI
- Chambers E., 2004, J. Controlled Release, 100, 111, 10.1016/j.jconrel.2004.08.005 · DOI · Paper page
- Chambers E., 2007, Exp. Biol. Med. (Maywood, NJ, U.S.), 232, 958
- Muzykantov V. R., 1985, FEBS Lett., 182, 62, 10.1016/0014-5793(85)81154-6 · DOI
- Muzykantov V. R., 2010, Exper. Opin. Drug Delivery, 7, 403, 10.1517/17425241003610633 · DOI
- Muzykantov V. R., 1986, Biochim. Biophys. Acta, 884, 355, 10.1016/0304-4165(86)90184-4 · DOI
- Zaitsev S., 2010, Blood, 115, 5241, 10.1182/blood-2010-01-261610 · DOI
- Danielyan K., 2008, Circulation, 118, 1442, 10.1161/CIRCULATIONAHA.107.750257 · DOI
- Yoon J.-Y., 1998, Colloids Surf., B, 12, 15, 10.1016/S0927-7765(98)00045-9 · DOI
- Yoon J.-Y., 1996, J. Colloid Interface Sci., 177, 613, 10.1006/jcis.1996.0075 · DOI
- Hayes S. H., 2009, Int. J. Clin. Exp. Pathol., 2, 553
- Kolhar P., 2013, Proc. Natl. Acad. Sci. U.S.A., 110, 10753, 10.1073/pnas.1308345110 · DOI
- Sikora L., 2003, Am. J. Pathol., 162, 2019, 10.1016/S0002-9440(10)64334-9 · DOI
- Fishman A., 1963, Handb. Physiol., 2, 1667
- Brain J. D., 1999, Am. J. Physiol.: Lung Cell. Mol. Physiol., 276, L146
- Warner A., 1986, Lab. Invest., 55, 276
- Warner A. E., 1986, Am. J. Physiol., 250, R728
- Moghimi S. M., 2001, Pharmacol. Rev., 53, 283
- Crosby W. H., 1959, Blood, 14, 399, 10.1182/blood.V14.4.399.399 · DOI
- Terpstra V., 2000, Blood, 95, 2157, 10.1182/blood.V95.6.2157 · DOI
- Muzykantov V. R., 2005, Exper. Opin. Drug Delivery, 2, 909, 10.1517/17425247.2.5.909 · DOI
- Muro S., 2008, Mol. Ther., 16, 1450, 10.1038/mt.2008.127 · DOI
- Scherpereel A., 2001, FASEB J., 15, 416, 10.1096/fj.00-0022com · DOI
- Ishihara T., 2009, Pharm. Res., 26, 2270, 10.1007/s11095-009-9943-x · DOI
- Ishida T., 2005, J. Controlled Release, 105, 305, 10.1016/j.jconrel.2005.04.003 · DOI
- Criado-Fornelio A., 2003, Vet. Microbiol., 93, 307, 10.1016/S0378-1135(03)00044-0 · DOI
- Stephan M. T., 2010, Nat. Med., 16, 1035, 10.1038/nm.2198 · DOI
- Doshi N., 2011, Adv. Mater., 23, H105, 10.1002/adma.201004074 · DOI
- Swiston A. J., 2010, Biomacromolecules, 11, 1826, 10.1021/bm100305h · DOI
- Muzykantov V. R., 1992, Int. J. Artif. Organs, 15, 622, 10.1177/039139889201501010 · DOI
Cited by
Sorted by citations
The evolution of commercial drug delivery technologies
Vargason, A. M., Anselmo, A. C., & Mitragotri, S. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00698-w · Cited by 1,361
Self-citationEmergence of Nanoplastic in the Environment and Possible Impact on Human Health
Lehner, R., Weder, C., Petri-Fink, A., & Rothen-Rutishauser, B. (2019) · Environmental Science & Technology · doi:10.1021/acs.est.8b05512 · Cited by 1,242
The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors
Izci, M., Maksoudian, C., Manshian, B. B., & Soenen, S. J. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00779 · Cited by 506
Antibiotic-loaded nanoparticles targeted to the site of infection enhance antibacterial efficacy
Hussain, S., Joo, J., Kang, J., Kim, B., Braun, G. B., She, Z.-G., Kim, D., Mann, A. P., Mölder, T., Teesalu, T., et al. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-017-0187-5 · Cited by 399
Organ-on-a-chip platforms for studying drug delivery systems
Bhise, N. S., Ribas, J., Manoharan, V., Zhang, Y. S., Polini, A., Massa, S., Dokmeci, M. R., & Khademhosseini, A. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.004 · Cited by 381
Metadata
- Authors
- Anselmo, A. C., Gupta, V., Zern, B. J., Pan, D., Zakrewsky, M., Muzykantov, V., & Mitragotri, S.
- Affiliations
- Department of Chemical Engineering and Center for Bioengineering University of California, Santa Barbara, California 93106, United States
- Department of Pharmacology and Center for Translational Targeted Therapeutics and Nanomedicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States
- Venue
- ACS Nano
- Publisher
- American Chemical Society (ACS)
- Published
- 2013-11-12
- Volume
- 7
- Issue
- 12
- Pages
- 11129-11137
- ISSN
- 1936-0851
- 1936-086X
- PMC
- PMC4128963
- Cited by
- 355
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review